Elypta is a Swedish molecular diagnostics company focused on reducing cancer mortality through early detection. Elypta is pioneering a metabolism-based liquid biopsy and measures the GAGome as system biomarkers of tumor metabolism. Machine learning algorithms are then used to detect signatures of cancer noninvasively. Elypta is advancing a broad clinical program with core indications in multi-cancer early detection and surveillance of recurrence in renal cell carcinoma.
Login or Register
You need to be logged in to use this feature.
Further Activities to have a look at